BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23881881)

  • 1. Consumption of new psychoactive substances in a Spanish sample of research chemical users.
    González D; Ventura M; Caudevilla F; Torrens M; Farre M
    Hum Psychopharmacol; 2013 Jul; 28(4):332-40. PubMed ID: 23881881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program].
    Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X
    Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
    Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
    Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
    Sande M
    Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Internet and psychoactive substance use among innovative drug users.
    Boyer EW; Shannon M; Hibberd PL
    Pediatrics; 2005 Feb; 115(2):302-5. PubMed ID: 15687436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
    Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
    Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-fatal injuries and the use of psychoactive drugs among young adults in Spain.
    Regidor E; Barrio G; de la Fuente L; Rodríguez C
    Drug Alcohol Depend; 1996 Mar; 40(3):249-59. PubMed ID: 8861404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Club drugs].
    Senn Ch; Bücheli A; Schaub M; Stohler R
    Ther Umsch; 2007 Feb; 64(2):109-13. PubMed ID: 17245678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Profile of psychoactive substances consumption in workplace].
    Bœuf-Cazou O; Lapeyre-Mestre M; Niezborala M; Montastruc JL
    Therapie; 2011; 66(2):155-65. PubMed ID: 21635864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
    Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
    Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drivers involved in road traffic accidents in Piedmont Region: psychoactive substances consumption.
    Siliquini R; Chiadò Piat S; Gianino MM; Renga G
    J Prev Med Hyg; 2007 Dec; 48(4):123-8. PubMed ID: 18557306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with psychoactive substance use among a sample of prison inmates in Ilesa, Nigeria.
    Amdzaranda PA; Fatoye FO; Oyebanji AO; Ogunro AS; Fatoye GK
    Niger Postgrad Med J; 2009 Jun; 16(2):109-14. PubMed ID: 19606190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013.
    Institóris L; Árok Z; Seprenyi K; Varga T; Sára-Klausz G; Keller É; Tóth RA; Sala L; Kereszty É; Róna K
    Forensic Sci Int; 2015 Mar; 248():181-6. PubMed ID: 25671307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone).
    Grifell M; Ventura M; Carbón X; Quintana P; Galindo L; Palma Á; Fornis I; Gil C; Farre M; Torrens M
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.